Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 4, 2010, Pages 868-869

  Al Sukaiti, Nashat ^a   Reid, Brenda ^a   Lavi, Sasson ^a   Al Zaharani, Daifulah ^a   Atkinson, Adelle ^a   Roifman, Chaim M ^a   Grunebaum, Eyal ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTHRITIS; CHROMOSOME 22Q; CHROMOSOME DELETION; DIGEORGE SYNDROME; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; IMMUNE FUNCTION TEST; LETTER; MEASLES; MUMPS; PRIORITY JOURNAL; RUBELLA; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 77957783161     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.07.018     Document Type: Article

References (9)

1. E.H. Moylett, A.N. Wasan, L.M. Noroski, and W.T. Shearer Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity Clin Immunol 112 2004 106 112
2. K.E. Sullivan Live viral vaccines in patients with DiGeorge syndrome Clin Immunol 113 2004 3
3. E.E. Perez, A. Bokszczanin, D. McDonald-McGinn, E.H. Zackai, and K.E. Sullivan Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Pediatrics 112 2003 e325
4. J.C. Watson, S.C. Hadler, C.A. Dykewicz, S. Reef, and L. Phillips Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 47 RR-8 1998 1 57
5. I. Davidkin, and M. Valle Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts Vaccine 16 1998 2052 2057
6. C. Azzari, E. Gambineri, M. Resti, M. Moriondo, L. Betti, and L.R. Saldias Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome) Vaccine 23 2005 1668 1671
7. A.K. Junker, and D.A. Driscoll Humoral immunity in DiGeorge syndrome J Pediatr 127 1995 231 237
8. L. Aurpibul, T. Puthanakit, T. Sirisanthana, and V. Sirisanthana Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy Clin Infect Dis 45 2007 637 642 (Pubitemid 47328647)
9. M. Shinjoh, I. Miyairi, K. Hoshino, T. Takahashi, and T. Nakayama Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation Vaccine 26 2008 6859 6863